RBC Capital Reiterates Sector Perform on Conifex Timber, Maintains C$2 Price Target
RBC Capital analyst Paul Quinn reiterates Conifex Timber (TSX:CFF) with a Sector Perform and maintains C$2 price target.
Credit Suisse Reiterates Outperform on Jasper Therapeutics, Maintains $4 Price Target
Credit Suisse analyst Judah Frommer reiterates Jasper Therapeutics (NASDAQ:JSPR) with a Outperform and maintains $4 price target.
Credit Suisse Reiterates Outperform on Dover, Maintains $174 Price Target
Credit Suisse analyst Guy Hardwick reiterates Dover (NYSE:DOV) with a Outperform and maintains $174 price target.
HC Wainwright & Co. Reiterates Buy on Protara Therapeutics, Maintains $23 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Protara Therapeutics (NASDAQ:TARA) with a Buy and maintains $23 price target.
EF Hutton Reiterates Buy on Troika Media Group, Maintains $1.5 Price Target
EF Hutton analyst Michael Albanese reiterates Troika Media Group (NASDAQ:TRKA) with a Buy and maintains $1.5 price target.
Canaccord Genuity Reiterates Buy on Nuvei, Maintains $70 Price Target
Canaccord Genuity analyst Joseph Vafi reiterates Nuvei (NASDAQ:NVEI) with a Buy and maintains $70 price target.
DA Davidson Reiterates Buy on Mattel, Maintains $23 Price Target
DA Davidson analyst Linda Bolton Weiser reiterates Mattel (NASDAQ:MAT) with a Buy and maintains $23 price target.
Trip.com Analyst Bumps Up Price Target By 9% As Recovery Underway
Mizuho analyst James Lee reiterated a Buy rating on the shares of Trip.com Group Ltd (NASDAQ:TCOM) and raised the price target from…
HC Wainwright & Co. Reiterates Overweight on Indaptus Therapeutics, Maintains $15 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Indaptus Therapeutics (NASDAQ:INDP) with a Overweight and maintains $15 price target.
Apple Stock Gets Price Target Bump On Rebounding Chinese iPhone Demand And This ‘Unappreciated Asset’
Sell-side’s optimism concerning Apple, Inc. (NASDAQ: AAPL) has been on the rise.